Scott Mendel
Director/Board Member at AKOYA BIOSCIENCES, INC.
Net worth: 337 237 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Darko Dejanovic | M | 53 | 13 years | |
| Jeffrey Hawkins | M | 46 | 2 years | |
| Brian McKelligon | M | 55 | 7 years | |
| Adam de la Zerda | M | - |
Visby Medical, Inc.
 Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | 12 years |
| Jonathan Rothberg | M | 60 | 11 years | |
| Ruth Fattori | F | 71 | 3 years | |
| Laura van't Veer | M | - |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 21 years |
| Johan Denecke | M | - | 1 years | |
| Christian LaPointe | M | 53 | 4 years | |
| Amir Jafri | M | 57 | 1 years | |
| Christoph Pereira | M | 51 | 17 years | |
| Matthew Winkler | M | 71 | 7 years | |
| John Kenny | M | 54 | 1 years | |
| René Bernards | M | 72 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 21 years |
| Thomas Schnettler | M | 67 | 5 years | |
| Kurt Becker | M | 50 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 12 years |
| Jeffry Keyes | M | 51 | 1 years | |
| Brigid Makes | F | 68 | 3 years | |
| Myla Lai-Goldman | M | 66 | 3 years | |
| Johnny Ek | M | 48 | 1 years | |
| Edward Neppl | M | 58 | 11 years | |
| Robert Shepler | M | 67 | 9 years | |
| Laurie Heilmann | F | 68 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 5 years |
| Priyam Shah | M | - | - | |
| An van Es-Johansson | M | 64 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Antoine Oijen | M | - | 11 years | |
| Mark Ibison | M | - |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | 3 years |
| Niro Ramachandran | M | 49 | 4 years | |
| Todd Rearick | M | - | 5 years | |
| Christy Garcia | F | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 3 years |
| Nadia Harbeck | F | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Fabrice André | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Elliot Shelton | M | - | 3 years | |
| Gavin Gordon | M | - | 4 years | |
| Jan Makela | M | - | 17 years | |
| Grace Johnston | M | 41 | 2 years | |
| Jennifer Kamocsay | F | 53 | 1 years | |
| Christine Quern | F | - | - | |
| M. William Audeh | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 8 years |
| Sujatha Chandrasekaran | F | 57 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 2 years |
| Pascal Bamford | M | - | 3 years | |
| Erik Esveld | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Patrick Balthrop | M | 67 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 7 years |
| Ronald Andrews | M | 64 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 1 years |
| John Kuo | M | 61 |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | 3 years |
| Kevin Rakin | M | 63 | 4 years | |
| David Schreiber | M | 64 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 1 years |
| Thomas Prescott | M | 68 |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | - |
| Amit Dilip Shah | M | 59 |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | - |
| François Ferré | M | 66 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 5 years |
| Shlomo Melmed | M | - |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | - |
| Peter Michael Stein | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Christoph Waer | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Peter J. Miller | M | - | 6 years | |
| Thomas Raffin | M | 77 | 9 years | |
| Mark R. Straley | M | 63 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 9 years |
| Ittai Harel | M | 56 |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | 6 years |
| Eric Moessinger | M | 43 |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | - |
| Terri Smith Bresenham | F | - |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | - |
| Jack Fuchs | M | - | 7 years | |
| Frederic Pla | M | 65 | 3 years | |
| Everett Cunningham | M | 57 |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | 2 years |
| Mark Medlen | M | - |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | - |
| Alex Hutcheson | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jon Belmonte | M | 56 | 12 years | |
| John Flannery | M | 63 | 14 years | |
| Michael McKenna | M | 61 | 9 years | |
| Garry Nolan | M | 63 | 9 years | |
| Michael Neal | M | 71 | 8 years | |
| Jamie Miller | F | 55 | - | |
| Patrick Schneider | M | 56 | 1 years | |
| Jerry Burris | M | 60 | 8 years | |
| Bastiaan van der Baan | M | 52 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 11 years |
| Joey Levin | M | 44 | 5 years | |
| Alexander Dimitrief | M | 65 | 12 years | |
| Robert Jeffe | M | 73 | 3 years | |
| Michael Barber | M | 64 | 16 years | |
| Dash Shrikant | M | - | 8 years | |
| Susan Hockfield | M | 73 | 12 years | |
| Bruns Grayson | M | 76 | 4 years | |
| William Castell | M | 76 | 7 years | |
| William Beattie | M | 64 | 10 years | |
| Robert W. Lane | M | 75 | 12 years | |
| James J. Mulva | M | 77 | - | |
| Jamere Jackson | M | 54 | 10 years | |
| Apoorv Dwivedi | M | 43 | 7 years | |
| Jason Garland | M | 50 | 5 years | |
| Li Li Xu | F | 43 | 9 years | |
| Emilie Schouten | F | 44 | 6 years | |
| Peter Clifford | M | 54 | 6 years | |
| Peter Batushansky | M | - | 2 years | |
| Carlo Luzzatto | M | 63 | 7 years | |
| Joe Schmitt | M | - | 10 years | |
| Billie Jo Cuthbert | F | 48 | 9 years | |
| Yan Jun Sun | M | 54 | 2 years | |
| Richard Stewart | M | 74 | 8 years | |
| Glen Messina | M | 62 | 3 years | |
| Tod A. Demeter | M | 60 | 4 years | |
| Joseph DeAngelo | M | 62 | 17 years | |
| Robert Daniel | M | - | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Scott Mendel
- Personal Network
